H Lundbeck A/S

H Lundbeck A/S Net Margin

The Net Profit Margin of H Lundbeck A/S (LUN.CO) as of Oct 14, 2026 is 13.11 %. In the previous year, Net Profit Margin was 14.28 % — a change of -8.23% (lower).

Net Margin

13.11 %

YoY

-8.23%

Last updated:

Net Profit Margin of H Lundbeck A/S is 2025 13.11 % . Net Profit Margin of H Lundbeck A/S was 2024 14.28 % . It decreases by -8.23% lower compared to the previous year.

H Lundbeck A/S's net margin stands at 13.1%, up from 8.1% several years earlier.

The H Lundbeck A/S Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
21.86 DKK
Jan 1, 2019
15.36 DKK
Jan 1, 2020
8.95 DKK
Jan 1, 2021
8.09 DKK
Jan 1, 2022
10.50 DKK
Jan 1, 2023
11.50 DKK
Jan 1, 2024
14.28 DKK
Jan 1, 2025
13.11 DKK
The H Lundbeck A/S Net Margin history
YEARNet MarginYoY
13.11 %-8.23%
14.28 %+24.20%
11.50 %+9.52%
10.50 %+29.86%
8.09 %-9.64%
8.95 %-41.76%
15.36 %-29.70%
21.86 %+43.56%
15.23 %+96.56%
7.75 %-119.85%
-39.02 %+3,334.43%
-1.14 %-2,127.31%
0.06 %-25.07%
0.07 %-47.54%
0.14 %-14.64%
0.17 %+14.40%
0.15 %-39.80%
0.24 %-20.55%
0.31 %+30.40%
0.23 %—
Access this data via the Eulerpool API
Get Free API Key

H Lundbeck A/S Stock analysis

What does H Lundbeck A/S do? H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about H Lundbeck A/S stock

Net Profit Margin of H Lundbeck A/S is 13.11 % in 2025.

Net Profit Margin of H Lundbeck A/S changed from 14.28 % to 13.11 %, representing a -8.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin H Lundbeck A/S since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's H Lundbeck A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — H Lundbeck A/S

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — H Lundbeck A/S